OxyGlutide

Semaglutide is a pharmaceutical compound that functions as an agonist of the glucagon-like peptide-1 (GLP-1) receptor. It is prescribed for managing type 2 diabetes mellitus and for supporting weight reduction in individuals with obesity. This medication promotes significant body weight and fat mass reduction primarily by lowering energy intake and influencing appetite regulation — strengthening the sensation of fullness while diminishing hunger signals. As a result, individuals experience improved control over eating behavior and a decreased desire for food, especially calorie-dense meals. Furthermore, semaglutide enhances insulin sensitivity, likely due to its impact on body weight loss, reduces the inclination toward high-fat foods, and by acting on specific regions within the brain it stimulates neurons associated with satiety and suppresses those linked to hunger, resulting in better appetite balance and long-term weight control.